| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/12/2007 | CN100353933C Instant oral medincinal preparation |
| 12/12/2007 | CN100353865C Chinese caterpillar fungus and gymnadenia conopsea combined series health products |
| 12/12/2007 | CN100353862C Fruit and vegetable effervescence tablet and its preparation method |
| 12/11/2007 | US7307156 Crystal forms of azithromycin |
| 12/11/2007 | US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide |
| 12/11/2007 | US7307058 Multimeric Apo A-I agonist compounds |
| 12/11/2007 | US7306950 Composition and use of substances for stabilising amino acids containing sulphur |
| 12/11/2007 | US7306822 Processing the layer of nanopowder dispersion or paste into passive electronic device function selected from resistor, varistor and inductor, capacitor |
| 12/11/2007 | US7306814 Calcium chloride solution was added to biopolymer such as low methoxy pectin, high methoxy pectin, kappa-carrageenan an solution in sodium bicarbonate (NaHCO3), precipitating encapsulating calcium carbonate salt |
| 12/11/2007 | US7306813 Nonwoven webs treated with fixed mobile materials |
| 12/11/2007 | US7306812 Dissolvable backing layer for use with a transmucosal delivery device |
| 12/11/2007 | US7306802 Ophthalmic compositions containing a synergistic combination of three polymers |
| 12/11/2007 | US7306801 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
| 12/11/2007 | US7306787 Engineered particles and methods of use |
| 12/11/2007 | US7306109 System and method of administering pharmaceuticals and nutraceuticals as part of a beverage container |
| 12/11/2007 | CA2444679C Tablet coating |
| 12/11/2007 | CA2370202C Gum pad for delivery of medication to mucosal tissues |
| 12/11/2007 | CA2346791C Flow resistance modulated aerosolized active agent delivery |
| 12/11/2007 | CA2304661C Parenteral formulations comprising carbamazepine or its derivatives |
| 12/11/2007 | CA2289462C Intrauterine chemical necrosing method, composition, and apparatus |
| 12/11/2007 | CA2227272C Use of lipids as aids in the production of solid drug forms by melt extrusion |
| 12/11/2007 | CA2226718C Transcorneal drug-release system |
| 12/11/2007 | CA2224164C Intrauterine chemical necrosing method and composition |
| 12/11/2007 | CA2220019C Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation |
| 12/11/2007 | CA2184077C Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 12/11/2007 | CA2180541C Food products for preventing development of diseases and process for preparing same |
| 12/11/2007 | CA2171618C Purine nucleoside phosphorylase gene therapy for human malignancy |
| 12/06/2007 | WO2007140416A2 Two-piece, internal-channel osmotic delivery system flow modulator |
| 12/06/2007 | WO2007140312A2 Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hydrogel formulations |
| 12/06/2007 | WO2007140285A2 Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists |
| 12/06/2007 | WO2007140267A1 Barrier film-forming germicidal compostition for controlling mastitis |
| 12/06/2007 | WO2007140235A2 Wound compresses and tourniquets |
| 12/06/2007 | WO2007140229A1 Instant brow lift and freeze |
| 12/06/2007 | WO2007140228A2 Nicotine-alternative compositions and methods of producing such compositions |
| 12/06/2007 | WO2007139936A2 Hyperthermic technologies comprising carbon micro- or nanotubes and therapeutic uses thereof |
| 12/06/2007 | WO2007139886A2 Duloxetine hydrochloride delayed release formulations |
| 12/06/2007 | WO2007139744A2 Implantable polymeric device for sustained release of buprenorphine with minimal initial burst |
| 12/06/2007 | WO2007139731A1 Neutral pharmaceuticals |
| 12/06/2007 | WO2007139661A1 Xylitol troches and methods of use |
| 12/06/2007 | WO2007139585A1 Controlled-release formulation |
| 12/06/2007 | WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound |
| 12/06/2007 | WO2007138997A1 Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof |
| 12/06/2007 | WO2007138606A2 Multiple unit pharmaceutical formulation |
| 12/06/2007 | WO2007138557A2 Controlled-release multiple unit pharmaceutical compositions |
| 12/06/2007 | WO2007138301A2 Novel formulation |
| 12/06/2007 | WO2007138231A1 Compositions comprising at least one naphthoic acid derivative and at least one film-forming agent, methods for preparing same, and uses thereof |
| 12/06/2007 | WO2007138225A1 Composition for controlling snoring, in the form of a nasal spray |
| 12/06/2007 | WO2007138224A1 Nasal and buccal compositions for controlling snoring |
| 12/06/2007 | WO2007138135A1 Bioadhesive nanoparticles for administration of biologically active molecules |
| 12/06/2007 | WO2007138086A1 Long term 24 hour intestinal administration of levodopa/carbidopa |
| 12/06/2007 | WO2007138022A2 Lipoic acid pellets |
| 12/06/2007 | WO2007138014A1 Compositions comprising glycosaminoglycans of low viscosity and use of said composition in therapy of chronic cystitis |
| 12/06/2007 | WO2007137802A2 Device and method for controlled delivery of chemical substances |
| 12/06/2007 | WO2007137732A2 Autodestructive transdermal therapeutic system |
| 12/06/2007 | WO2007115381A3 Solid dispersion of poorly soluble drugs in graft copolymers |
| 12/06/2007 | WO2007109057A3 Solid dosage form containing a taste masked active agent |
| 12/06/2007 | WO2007103873A3 Pharmaceutical formulations of an anhydrous crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 12/06/2007 | WO2007103869A3 Liquid and semi-solid pharmaceutical formulations and processes |
| 12/06/2007 | WO2007099555A3 Pharmaceutical tablet compositions containing irbesartan |
| 12/06/2007 | WO2007097889A3 Fluoroquinolone compositions |
| 12/06/2007 | WO2007097770A8 Metoprolol succinate e.r. tablets and methods for their preparation |
| 12/06/2007 | WO2007092338A3 Compositions comprising a bisphosphonate and an antifolate |
| 12/06/2007 | WO2007089876A3 Preparation for gastric buoyant sustained drug release dosage form |
| 12/06/2007 | WO2007084313A3 Abuse resistant transdermal drug delivery |
| 12/06/2007 | WO2007084212A3 Biologically active composition comprising ethylcellulose |
| 12/06/2007 | WO2007072992A3 Solid preparation containing an insulin sensitizer |
| 12/06/2007 | WO2007067520A3 Lipid-based compositions of antiinfectives for treating pulmonary infections |
| 12/06/2007 | WO2007056491A3 Film-forming resins as a carrier for topical application of pharmacologically active agents |
| 12/06/2007 | WO2007053533A3 Sodium chloride solution for drug reconstitution or dilution |
| 12/06/2007 | WO2007048634A3 Nanoparticles of a heterocrystal mineral for use as a medicament and method of producing the same |
| 12/06/2007 | WO2007047371A3 Pharmaceutical packaging of an oral dosage combination |
| 12/06/2007 | WO2007022188A3 A porous non-biodegradable hydrogel admixed with a chemoattractant for tissue replacement |
| 12/06/2007 | WO2007010584A3 Controlled-delivery system of pharmacologically active substances, preparation process and medical use thereof |
| 12/06/2007 | WO2007001355A3 Enhanced stability of proteins immobilized on nanoparticles |
| 12/06/2007 | WO2006138026A3 Stable pharmaceutical compositions including motilin-like peptides |
| 12/06/2007 | WO2006122183A3 Injectable hydrogels and methods of making and using same |
| 12/06/2007 | WO2006108692A3 Dosage form for oral administration of a vitamin |
| 12/06/2007 | WO2006075097A3 Pharmaceutical composition and galenic form corresponding to a rapid oral disintegration and method for production of said composition |
| 12/06/2007 | WO2004064109A3 Water soluble metal and semiconductor nanoparticle complexes |
| 12/06/2007 | WO2003034822A3 Powdery active ingredient formulations |
| 12/06/2007 | US20070282373 Hemostatic Pressure Plug |
| 12/06/2007 | US20070282053 Emulsification of concentrated dispersions of colloidal and nanoparticles |
| 12/06/2007 | US20070282014 Hydroxyethylstarch |
| 12/06/2007 | US20070282013 Pharmaceutical Compositions Comprising Peranhydrocyclodextrin |
| 12/06/2007 | US20070282009 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 12/06/2007 | US20070281926 Rectal Composition |
| 12/06/2007 | US20070281878 Particle-Stabilised Emulsions |
| 12/06/2007 | US20070281036 System and method of delivering a desired material to a cell |
| 12/06/2007 | US20070281035 Release coating and process |
| 12/06/2007 | US20070281034 Magnetic microparticles comprising organic substances |
| 12/06/2007 | US20070281032 Method for generating polymeric wear particles |
| 12/06/2007 | US20070281031 Microparticles and methods for production thereof |
| 12/06/2007 | US20070281030 Non-Lamellar Compositions of Dope and P80 |
| 12/06/2007 | US20070281029 Method for preparing high absorbent hydrocolloid |
| 12/06/2007 | US20070281028 Drug Delivery of a Cox Inhibitor from Embolic Agents |
| 12/06/2007 | US20070281027 Multilaminate backing construction |
| 12/06/2007 | US20070281026 Elastin stabilization of connective tissue |
| 12/06/2007 | US20070281025 Cholesterol-Interacting Layered Phyllosilicates and Methods of Reducing Hypercholesteremia in a Mammal |
| 12/06/2007 | US20070281024 Two-Piece, Internal-Channel Osmotic Delivery System Flow Modulator |
| 12/06/2007 | US20070281023 Pharmaceutical composition for modified release insulin sensitiser |